Another study showed that CCDC3 can inhibit migration and invasion of prostate cancer cells, suggesting that CCDC3 possesses anticancer actions in prostate cancer (Ke et al., 2022), similar to its tumor-suppressive role in BrC (Li et al., 2023a; Figure 3). The gene discussed is CCDC3; the disease is Familial prostate cancer.